GTC
PRQR icon

Ghost Tree Capital’s ProQR Therapeutics PRQR Stock Holding History

Ghost Tree Capital’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.62M Sell
887,700
-12,300
-1% -$23.1K 0.49% 50
2024
Q2 		$1.49M Buy
+900,000
New +$1.75M 0.47% 49

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ghost Tree Capital's PRQR Position: Q3 2024 in Review

Ghost Tree Capital reduced its ProQR Therapeutics (PRQR) stake by 1.4% in Q3 2024, selling an estimated $23.1K and leaving 887,700 shares worth $1.62M. The position accounts for 0.49% of the portfolio, ranked #50.

Ghost Tree Capital first reported a position in PRQR in Q2 2024 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold PRQR as of Q3 2024.

  • Ghost Tree Capital held 887,700 shares of ProQR Therapeutics worth $1.62M as of Q3 2024.
  • Ghost Tree Capital sold 12,300 ProQR Therapeutics shares in Q3 2024, an estimated $23.1K.
  • ProQR Therapeutics made up 0.49% of Ghost Tree Capital's portfolio in Q3 2024, its #50 holding.
  • Ghost Tree Capital first reported a position in ProQR Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.